The Nrf2/HO-1 activator is an effective therapy for amyotrophic lateral sclerosis [36], Alzheimer’s disease [37], Parkinson’s disease [38], Huntington’s disease [39], and intracerebral hemorrhage [40]. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.